Report Detail
COVID-19 Impact on Global Medical Radioisotopes Market Size, Status and Forecast 2020-2026
- RnM4094546 |
- 09 July, 2020 |
- Global |
- 93 Pages |
- QYResearch |
- Other
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life (see also information paper on The Many Uses of Nuclear Technology).There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Analysis and Insights: Global Medical Radioisotopes Market
The global Medical Radioisotopes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medical Radioisotopes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medical Radioisotopes market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medical Radioisotopes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medical Radioisotopes market.
Medical Radioisotopes Breakdown Data by Type
Mo-99
Co-60
Lutetium 177
Medical Radioisotopes Breakdown Data by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Based on regional and country-level analysis, the Medical Radioisotopes market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Medical Radioisotopes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
NRG
NTP Radioisotopes
ANSTO
IRE
Nordion
Curium Pharma
Eckert & Ziegler Strahlen
Polatom
China National Nuclear Corporation
IDB Holland
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Medical Radioisotopes Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Mo-99
- 1.2.3 Co-60
- 1.2.4 Lutetium 177
- 1.3 Market by Application
- 1.3.1 Global Medical Radioisotopes Market Share by Application: 2020 VS 2026
- 1.3.2 Nuclear Therapy
- 1.3.3 Equipment Radioactive Source
- 1.3.4 Diagnosis
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Medical Radioisotopes Market Perspective (2015-2026)
- 2.2 Global Medical Radioisotopes Growth Trends by Regions
- 2.2.1 Medical Radioisotopes Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Medical Radioisotopes Historic Market Share by Regions (2015-2020)
- 2.2.3 Medical Radioisotopes Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Medical Radioisotopes Players by Market Size
- 3.1.1 Global Top Medical Radioisotopes Players by Revenue (2015-2020)
- 3.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2015-2020)
- 3.2 Global Medical Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Medical Radioisotopes Revenue
- 3.4 Global Medical Radioisotopes Market Concentration Ratio
- 3.4.1 Global Medical Radioisotopes Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Medical Radioisotopes Revenue in 2019
- 3.5 Key Players Medical Radioisotopes Area Served
- 3.6 Key Players Medical Radioisotopes Product Solution and Service
- 3.7 Date of Enter into Medical Radioisotopes Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Radioisotopes Breakdown Data by Type (2015-2026)
- 4.1 Global Medical Radioisotopes Historic Market Size by Type (2015-2020)
- 4.2 Global Medical Radioisotopes Forecasted Market Size by Type (2021-2026)
5 Medical Radioisotopes Breakdown Data by Application (2015-2026)
- 5.1 Global Medical Radioisotopes Historic Market Size by Application (2015-2020)
- 5.2 Global Medical Radioisotopes Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Medical Radioisotopes Market Size (2015-2026)
- 6.2 North America Medical Radioisotopes Market Size by Type (2015-2020)
- 6.3 North America Medical Radioisotopes Market Size by Application (2015-2020)
- 6.4 North America Medical Radioisotopes Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Medical Radioisotopes Market Size (2015-2026)
- 7.2 Europe Medical Radioisotopes Market Size by Type (2015-2020)
- 7.3 Europe Medical Radioisotopes Market Size by Application (2015-2020)
- 7.4 Europe Medical Radioisotopes Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Medical Radioisotopes Market Size (2015-2026)
- 8.2 China Medical Radioisotopes Market Size by Type (2015-2020)
- 8.3 China Medical Radioisotopes Market Size by Application (2015-2020)
- 8.4 China Medical Radioisotopes Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Medical Radioisotopes Market Size (2015-2026)
- 9.2 Japan Medical Radioisotopes Market Size by Type (2015-2020)
- 9.3 Japan Medical Radioisotopes Market Size by Application (2015-2020)
- 9.4 Japan Medical Radioisotopes Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Medical Radioisotopes Market Size (2015-2026)
- 10.2 Southeast Asia Medical Radioisotopes Market Size by Type (2015-2020)
- 10.3 Southeast Asia Medical Radioisotopes Market Size by Application (2015-2020)
- 10.4 Southeast Asia Medical Radioisotopes Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 NRG
- 11.1.1 NRG Company Details
- 11.1.2 NRG Business Overview
- 11.1.3 NRG Medical Radioisotopes Introduction
- 11.1.4 NRG Revenue in Medical Radioisotopes Business (2015-2020))
- 11.1.5 NRG Recent Development
- 11.2 NTP Radioisotopes
- 11.2.1 NTP Radioisotopes Company Details
- 11.2.2 NTP Radioisotopes Business Overview
- 11.2.3 NTP Radioisotopes Medical Radioisotopes Introduction
- 11.2.4 NTP Radioisotopes Revenue in Medical Radioisotopes Business (2015-2020)
- 11.2.5 NTP Radioisotopes Recent Development
- 11.3 ANSTO
- 11.3.1 ANSTO Company Details
- 11.3.2 ANSTO Business Overview
- 11.3.3 ANSTO Medical Radioisotopes Introduction
- 11.3.4 ANSTO Revenue in Medical Radioisotopes Business (2015-2020)
- 11.3.5 ANSTO Recent Development
- 11.4 IRE
- 11.4.1 IRE Company Details
- 11.4.2 IRE Business Overview
- 11.4.3 IRE Medical Radioisotopes Introduction
- 11.4.4 IRE Revenue in Medical Radioisotopes Business (2015-2020)
- 11.4.5 IRE Recent Development
- 11.5 Nordion
- 11.5.1 Nordion Company Details
- 11.5.2 Nordion Business Overview
- 11.5.3 Nordion Medical Radioisotopes Introduction
- 11.5.4 Nordion Revenue in Medical Radioisotopes Business (2015-2020)
- 11.5.5 Nordion Recent Development
- 11.6 Curium Pharma
- 11.6.1 Curium Pharma Company Details
- 11.6.2 Curium Pharma Business Overview
- 11.6.3 Curium Pharma Medical Radioisotopes Introduction
- 11.6.4 Curium Pharma Revenue in Medical Radioisotopes Business (2015-2020)
- 11.6.5 Curium Pharma Recent Development
- 11.7 Eckert & Ziegler Strahlen
- 11.7.1 Eckert & Ziegler Strahlen Company Details
- 11.7.2 Eckert & Ziegler Strahlen Business Overview
- 11.7.3 Eckert & Ziegler Strahlen Medical Radioisotopes Introduction
- 11.7.4 Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2015-2020)
- 11.7.5 Eckert & Ziegler Strahlen Recent Development
- 11.8 Polatom
- 11.8.1 Polatom Company Details
- 11.8.2 Polatom Business Overview
- 11.8.3 Polatom Medical Radioisotopes Introduction
- 11.8.4 Polatom Revenue in Medical Radioisotopes Business (2015-2020)
- 11.8.5 Polatom Recent Development
- 11.9 China National Nuclear Corporation
- 11.9.1 China National Nuclear Corporation Company Details
- 11.9.2 China National Nuclear Corporation Business Overview
- 11.9.3 China National Nuclear Corporation Medical Radioisotopes Introduction
- 11.9.4 China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2015-2020)
- 11.9.5 China National Nuclear Corporation Recent Development
- 11.10 IDB Holland
- 11.10.1 IDB Holland Company Details
- 11.10.2 IDB Holland Business Overview
- 11.10.3 IDB Holland Medical Radioisotopes Introduction
- 11.10.4 IDB Holland Revenue in Medical Radioisotopes Business (2015-2020)
- 11.10.5 IDB Holland Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Medical Radioisotopes. Industry analysis & Market Report on COVID-19 Impact on Global Medical Radioisotopes is a syndicated market report, published as COVID-19 Impact on Global Medical Radioisotopes Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Medical Radioisotopes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
